Panakes Partners

Panakes Partners is a Milan-based venture capital firm founded in 2015 that specializes in early-stage investments in life sciences and healthcare across Europe and Israel. It backs ambitious teams developing innovative technologies and products to improve human health, providing capital and strategic guidance to move scientific discoveries toward practical market applications.

Lorenzo Giordano

CFO

Giacomo Piccinini

Associate

Alessio Piuma

Investment Manager

Alessio Piuma

Investment Manager

Marco Sardina Ph.D

Scientific Partner

Robbie Woodman Ph.D

Partner

Rob Woodman

Partner

Rob Woodman

Partner

Past deals in Italy

TENSIVE

Series A in 2025
TENSIVE s.r.l. is a biomedical company based in Milan, Italy, founded in 2012. It specializes in the development of innovative prostheses for natural breast reconstruction and augmentation. The company's products utilize biodegradable synthetic biomaterials and feature an internal micro-architecture that mimics blood vessel structures. These vascularized prostheses aim to enhance the quality of life for patients undergoing treatment for breast cancer, offering a solution that reduces the need for recurrent and costly surgical interventions. Through its focus on advanced biomaterials and design, TENSIVE seeks to provide effective and sustainable options for breast reconstruction.

BetaGlue Technologies

Seed Round in 2022
BetaGlue Technologies SpA is a Milan-based company that specializes in the development and manufacture of medical devices designed for loco-regional radiation therapy targeting unresectable solid tumors. The company's innovative product features a proprietary beta-emitting biocompatible matrix, which facilitates the controlled administration of radionuclides directly into tumor masses. This technology not only enhances the effectiveness of cancer treatment but also plays a crucial role in preventing complications that can arise following procedures such as lung and liver biopsies. By focusing on localized therapies, BetaGlue Technologies aims to improve patient outcomes and advance the field of cancer treatment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.